APG Asset Management N.V. lifted its stake in shares of Waters Co. (NYSE:WAT - Free Report) by 155.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 54,144 shares of the medical instruments supplier's stock after purchasing an additional 32,953 shares during the period. APG Asset Management N.V. owned 0.09% of Waters worth $19,398,000 at the end of the most recent quarter.
A number of other hedge funds also recently modified their holdings of WAT. Envestnet Portfolio Solutions Inc. increased its holdings in Waters by 15.5% in the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 3,587 shares of the medical instruments supplier's stock worth $1,331,000 after acquiring an additional 482 shares during the last quarter. Barclays PLC increased its stake in shares of Waters by 34.8% in the third quarter. Barclays PLC now owns 159,995 shares of the medical instruments supplier's stock worth $57,579,000 after purchasing an additional 41,339 shares in the last quarter. Savant Capital LLC raised its position in shares of Waters by 3.8% in the fourth quarter. Savant Capital LLC now owns 1,704 shares of the medical instruments supplier's stock valued at $632,000 after purchasing an additional 63 shares during the period. Robeco Institutional Asset Management B.V. lifted its stake in shares of Waters by 7.1% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 421,691 shares of the medical instruments supplier's stock valued at $156,439,000 after buying an additional 27,801 shares in the last quarter. Finally, Czech National Bank boosted its holdings in Waters by 6.5% in the 4th quarter. Czech National Bank now owns 12,874 shares of the medical instruments supplier's stock worth $4,776,000 after buying an additional 782 shares during the period. Institutional investors own 94.01% of the company's stock.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on WAT. UBS Group increased their target price on Waters from $405.00 to $410.00 and gave the stock a "neutral" rating in a research report on Thursday, February 13th. Wells Fargo & Company increased their price objective on Waters from $415.00 to $420.00 and gave the stock an "overweight" rating in a report on Thursday, February 13th. Scotiabank raised Waters from a "sector perform" rating to a "sector outperform" rating and lifted their target price for the company from $430.00 to $450.00 in a report on Thursday, February 13th. Barclays decreased their price target on Waters from $400.00 to $350.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. Finally, Bank of America reduced their price objective on shares of Waters from $430.00 to $410.00 and set a "neutral" rating for the company in a research note on Thursday, February 13th. Ten research analysts have rated the stock with a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $397.25.
Check Out Our Latest Report on WAT
Waters Trading Down 3.3 %
Shares of WAT stock traded down $11.01 on Tuesday, hitting $322.76. 146,749 shares of the company's stock traded hands, compared to its average volume of 474,655. The stock has a market capitalization of $19.18 billion, a price-to-earnings ratio of 30.14, a P/E/G ratio of 3.79 and a beta of 1.04. The company's fifty day simple moving average is $367.21 and its 200 day simple moving average is $372.32. Waters Co. has a one year low of $279.24 and a one year high of $423.56. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94.
Waters (NYSE:WAT - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. Equities analysts forecast that Waters Co. will post 12.86 EPS for the current year.
About Waters
(
Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Recommended Stories
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
